GlassScriptPhysician profile
Akash Bajaj
NPI 1689752164
$13,559.82
in general payments reported to CMS, 2019-2025
34 companies · $1,013 in 2025
The $1,013 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,863 · 2020: $2,809 · 2021: $1,968 · 2022: $1,535 · 2023: $1,652 · 2024: $1,720 · 2025: $1,013.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,384.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,849.64 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, General - Pain Management |
| Abbott Laboratories | $2,555.02 | 2019-2025 | Proclaim, Eterna, Octrode |
| Medtronic USA, INC. | $1,923.97 | 2019-2020 | |
| Medtronic, INC. | $1,241.05 | 2021-2025 | Intellis Adaptivestim, Plasmablade(Tm), Accurian |
| Vertiflex, INC. | $1,051.42 | 2019 | |
| Relievant Medsystems, INC. | $487.56 | 2019-2021 | |
| Nevro Corp. | $437.67 | 2019-2024 | Senza |
| Merz Pharmaceuticals, LLC | $364.85 | 2021-2025 | Xeomin |
| Saluda Medical Americas, INC. | $255.84 | 2024-2025 | Evoke |
| Spr Therapeutics, INC | $188.93 | 2019-2024 | Sprint Pns System |
| Merz North America, INC. | $187.93 | 2019-2020 | |
| Nalu Medical, INC. | $112.61 | 2023 | Nalu Neurostimulation System |
| Allergan, INC. | $108.87 | 2019 | |
| Spinesmith Holdings, LLC | $79.89 | 2019 | |
| Stratus Medical, LLC | $66.58 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $63.56 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Lilly USA, LLC | $63.12 | 2020 | |
| Painteq LLC | $62.50 | 2022-2023 | Painteq |
| Globus Medical, INC. | $54.20 | 2025 | Senza |
| Pacira Pharmaceuticals Incorporated | $51.67 | 2022-2023 | Iovera, Zilretta |
| Collegium Pharmaceutical, INC. | $50.22 | 2019 | |
| Stimwave Technologies Incorporated | $42.74 | 2019 | |
| Si-Bone, INC. | $34.58 | 2019 | |
| Vertos Medical, INC. | $32.94 | 2021 | |
| Zimmer Biomet Holdings, INC. | $23.45 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $21.86 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $21.77 | 2024 | |
| Ibsa Pharma INC. | $21.27 | 2020 | |
| Spinal Simplicity, LLC | $20.45 | 2022 | |
| Pfizer INC. | $19.88 | 2019 | |
| Terumo Bct, INC. | $18.02 | 2019 | |
| Lundbeck LLC | $17.55 | 2020 | |
| Horizon Therapeutics Plc | $14.21 | 2019 | |
| Medline Industries LP | $14.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akash Bajaj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.